Michael T. Young

Michael T. Young

Auto-generated profile, based on publicly available information

Michael T. Young

Department of Environmental and Occupational Health Sciences, Seattle, WA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2016 in Environmental Science & Technology
Verified
Journal Article
Closed access
MYMichael T. Young
Michael T. Young
MBMatthew J. Bechle
Matthew J. Bechle
PSPaul D. Sampson
Paul D. Sampson
ASAdam A. Szpiro
Adam A. Szpiro
JMJulian D. Marshall
Julian D. Marshall
JKJoel Kaufman
Joel Kaufman


28 November 2024 in Environmental Pollution
Verified
Journal Article
Closed access
Meng WangMeng Wang
Meng Wang
MYMichael Young
Michael Young
JMJulian D. Marshall
Julian D. Marshall
LPLogan Piepmeier
Logan Piepmeier
Jianzhao BiJianzhao Bi
Jianzhao Bi
ASAdam A. Szpiro
Adam A. Szpiro

6 March 2025 in Blood
Verified
Journal Article
Closed access
PLPamela Lutsey
Pamela Lutsey
JMJeffrey R. Misialek
Jeffrey R. Misialek
MYMichael T. Young
Michael T. Young
JBJesse Berman
Jesse Berman
CLClaire L. Leiser
Claire L. Leiser
JKJoel Kaufman
Joel Kaufman
Air pollution exposure may induce procoagulant effects, and chronic exposure may be linked to greater risk of venous thromboembolism (VTE). We tested the hypothesis that air pollution is associated with increased VTE risk in the prospective Multi-Ethnic Study of Atherosclerosis, which has well-characterized air pollution measures and information on potential confounding factors. We included 6651 participants recruited in 2000 to 2002 (baseline age range, 45-84 years; 53% female). Air pollution was assessed with a validated spatiotemporal model that incorporates cohort-specific monitoring. Four indexes of air pollution updated each fortnight over follow-up were averaged to estimate participant-level chronic exposure: fine particulate matter ≤2.5 micrometers in aerodynamic diameter (PM2.5), oxides of nitrogen (NOx), nitrogen dioxide (NO2), and ozone (O3). Mean±SD PM2.5 was 13.5±3.0 μg/m3, NO2 17.9±8.2 parts per billion (ppb), NOx 36.1±19.6 ppb, and O3 22.2±3.7 ppb. Incident VTE was identified using hospitalization discharge codes through 2018. A total of 248 VTE events accrued over a median follow-up of 16.7 years. After adjustment for baseline demographics, health behaviors, and body mass index, the hazard ratio (95% confidence interval) for incident VTE associated per 3.6 μg/m3 higher PM2.5 was 1.39 (1.04-1.86); per 13.3 ppb higher NO2 concentration was 2.74 (1.57-4.77); and per 30 ppb higher NOx was 2.21 (1.42-3.44). O3 was not related. In this prospective community-based cohort with individual-level estimation of chronic air pollution exposure, higher average ambient concentrations of PM2.5, NO2, and NOX were associated with greater risk of developing VTE. Findings add to accumulating evidence of adverse health effects attributed to air pollution exposure.

1 December 2023 in Annals of Internal Medicine
Verified
Journal Article
Closed access
MYMichael T. Young
Michael T. Young
KJKaren Jansen
Karen Jansen
KCKristen E. Cosselman
Kristen E. Cosselman
TGTimothy R. Gould
Timothy R. Gould
JSJames A. Stewart
James A. Stewart
JKJoel Kaufman
Joel Kaufman
Ambient air pollution, including traffic-related air pollution (TRAP), increases cardiovascular disease risk, possibly through vascular alterations. Limited information exists about in-vehicle TRAP exposure and vascular changes. To determine via particle filtration the effect of on-roadway TRAP exposure on blood pressure and retinal vasculature. Randomized crossover trial. (ClinicalTrials.gov: NCT05454930). In-vehicle scripted commutes driven through traffic in Seattle, Washington, during 2014 to 2016. Normotensive persons aged 22 to 45 years (n = 16). On 2 days, on-road air was entrained into the vehicle. On another day, the vehicle was equipped with high-efficiency particulate air (HEPA) filtration. Participants were blinded to the exposure and were randomly assigned to the sequence. Fourteen 3-minute periods of blood pressure were recorded before, during, and up to 24 hours after a drive. Image-based central retinal arteriolar equivalents (CRAEs) were measured before and after. Brachial artery diameter and gene expression were also measured and will be reported separately. Mean age was 29.7 years, predrive systolic blood pressure was 122.7 mm Hg, predrive diastolic blood pressure was 70.8 mm Hg, and drive duration was 122.3 minutes (IQR, 4 minutes). Filtration reduced particle count by 86%. Among persons with complete data (n = 13), at 1 hour, mean diastolic blood pressure, adjusted for predrive levels, order, and carryover, was 4.7 mm Hg higher (95% CI, 0.9 to 8.4 mm Hg) for unfiltered drives compared with filtered drives, and mean adjusted systolic blood pressure was 4.5 mm Hg higher (CI, -1.2 to 10.2 mm Hg). At 24 hours, adjusted mean diastolic blood pressure (unfiltered) was 3.8 mm Hg higher (CI, 0.02 to 7.5 mm Hg) and adjusted mean systolic blood pressure was 1.1 mm Hg higher (CI, -4.6 to 6.8 mm Hg). Adjusted mean CRAE (unfiltered) was 2.7 μm wider (CI, -1.5 to 6.8 μm). Imprecise estimates due to small sample size; seasonal imbalance by exposure order. Filtration of TRAP may mitigate its adverse effects on blood pressure rapidly and at 24 hours. Validation is required in larger samples and different settings. U.S. Environmental Protection Agency and National Institutes of Health.

5 April 2016 in Neurology
Verified
Journal Article
Closed access
RLRui Liu
Rui Liu
MYMichael Young
Michael Young
JCJiu-Chiuan Chen
Jiu-Chiuan Chen
JKJoel Kaufman
Joel Kaufman
HCHonglei Chen
Honglei Chen